Cellular health

Coenzyme Q10 (CoQ10): Benefits, Dosage, and Safety — A Complete Guide

A fat-soluble cofactor essential for cellular energy production and a powerful antioxidant. Here is what the most recent meta-analyses indexed on PubMed actually show — translated into practical guidance for adults in Switzerland.

Coenzyme Q10 capsules — Swiss food supplement for cellular energy and cardiovascular health
Coenzyme Q10 (CoQ10), sometimes referred to as vitamin Q10, is a fat-soluble compound found in every cell, central to cellular energy production and acting as a powerful antioxidant. Endogenous synthesis begins to decline gradually from the age of 20 to 30, which is why supplementation is sometimes considered. But what does the clinical evidence on PubMed actually demonstrate — and what is overstated by marketing? This evidence-based guide separates well-documented benefits from those still under debate, drawing on recent meta-analyses and randomised controlled trials. Practical guidance is adapted to the Swiss context, with Federal Food Safety and Veterinary Office (FSVO/OSAV) standards in mind.

What is coenzyme Q10 (CoQ10)?

A naturally occurring, fat-soluble compound

Coenzyme Q10 is a lipid-soluble quinone synthesised by the body itself. It exists in two interconvertible forms: ubiquinone (oxidised) and ubiquinol (reduced, biologically active). Roughly 90 % of plasma CoQ10 in healthy adults circulates as ubiquinol.

Where CoQ10 is found in the body

CoQ10 sits in the inner mitochondrial membrane of every cell, with the highest concentrations in tissues with the greatest energy demand: heart, liver, kidneys, and skeletal muscle. The myocardium, in particular, holds among the densest concentrations in the human organism.

Why CoQ10 levels decline with age — and what affects them

Endogenous CoQ10 production peaks in the third decade of life and decreases steadily thereafter. Statin therapy (which inhibits the same mevalonate pathway used to synthesise CoQ10), chronic inflammation, oxidative stress, certain genetic conditions, and diabetes are all associated with lower tissue and plasma CoQ10 concentrations.

How does CoQ10 work? Energy and antioxidant protection

CoQ10 and ATP production in the mitochondria

CoQ10 is an indispensable cofactor in the mitochondrial respiratory chain, shuttling electrons between complexes I/II and III during oxidative phosphorylation to produce adenosine triphosphate (ATP) — the energy currency of every cell. Without functional CoQ10, the body cannot generate cellular energy from food efficiently.

CoQ10 as a powerful antioxidant: neutralising free radicals

In its reduced form (ubiquinol), CoQ10 neutralises free radicals, protects cell membranes and LDL lipoproteins from lipid peroxidation, and contributes to the regeneration of vitamin E from its oxidised form (tocopheroxyl radical). It is one of the few antioxidants the human body produces endogenously.

Anti-inflammatory effects at the cellular level

The 2023 GRADE meta-analysis by Hou et al. (31 RCTs, 1 517 subjects) confirms a significant reduction in inflammatory markers — C-reactive protein (CRP), interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) — with an optimal daily intake of 300–400 mg.3 Vascular endothelial function also improves, which is one of the mechanisms underlying CoQ10's cardiovascular benefits.

Key point

CoQ10 plays two biological roles that rarely coexist: ATP production and antioxidant defence. This dual function explains its clinical relevance in conditions where mitochondrial dysfunction and oxidative stress overlap.

Proven health benefits of CoQ10

The strength of evidence varies considerably across indications. The summary below honestly reflects what recent meta-analyses on PubMed support — and what they don't.

Heart health and cardiovascular disease

The Q-SYMBIO trial (Mortensen et al., JACC: Heart Failure, 2014, 420 patients with chronic heart failure) showed that 3 × 100 mg/day of CoQ10 over two years significantly reduced the risk of major adverse cardiovascular events (15 % vs 26 %, HR 0.50), cardiovascular mortality (9 % vs 16 %) and all-cause mortality (10 % vs 18 %). The 2022 GRADE meta-analysis by Zhao et al. (26 RCTs, 1 831 subjects) confirms a systolic blood pressure reduction of −4.77 mmHg, with a U-shaped dose–response and an optimal range of 100–200 mg/day. Smaller perioperative trials have explored CoQ10 before cardiac surgery to reduce ischaemia-reperfusion injury, with promising but inconsistent results — not yet sufficient to support a routine recommendation.12

−50 % reduction in major adverse cardiovascular events (MACE) with 3 × 100 mg/day of CoQ10 over two years in patients with chronic heart failure (Q-SYMBIO, HR 0.50).

Migraine prevention

The pioneering trial by Sándor et al. (Neurology, 2005), conducted at the University Hospital of Zurich 🇨🇭, remains a landmark: at 3 × 100 mg/day, 47.6 % of patients achieved a ≥ 50 % reduction in migraine attack frequency (vs 14.4 % on placebo, NNT = 3). The 2021 BMJ Open meta-analysis by Sazali et al. (6 RCTs, 371 participants) confirms significant reductions in frequency and duration of migraine attacks — but not in severity. Effective dosages range from 200–300 mg/day over 8–12 weeks.5

Blood sugar regulation and type 2 diabetes

The meta-analysis by Zhang et al. (2018, 13 RCTs, 765 patients with type 2 diabetes) showed that CoQ10 supplementation modestly reduces glycated haemoglobin (HbA1c by approximately 0.29 percentage points) and fasting blood glucose (by approximately −11.2 mg/dL) when used alongside standard antidiabetic therapy. Effects on fasting insulin were not statistically significant. CoQ10 is therefore an adjunct, not a replacement for medical treatment.10

Skin health and anti-ageing

The 2024 review by Lain et al. (36 publications) highlights that topical CoQ10 reduces wrinkle depth and contributes to antioxidative protection of cutaneous tissue. Evidence for oral supplementation on cutaneous outcomes is more limited — some trials report modest improvements in skin elasticity and pigmentation in older women, but the effect size remains small.7

Male and female fertility

The systematic review and meta-analysis by Salas-Huetos et al. (2018, 28 articles, 15 RCTs) found that CoQ10 supplementation improves sperm concentration (+5.93 × 10⁶ spermatozoa/mL) and sperm motility (+5.30 %) in men with idiopathic infertility. The 2025 network meta-analysis by Niu et al. (16 trials) identified CoQ10 as the most effective intervention for improving sperm concentration. Evidence for female fertility (egg quality, ovarian reserve) is more preliminary, drawn from smaller observational studies.11

Neurological support — Parkinson's disease and other conditions

Despite its theoretical rationale (mitochondrial dysfunction is implicated in Parkinson's disease pathology), the meta-analysis by Zhu et al. (2016, 8 RCTs, 899 patients) found that CoQ10 was not superior to placebo for motor symptoms (UPDRS scores). Tolerance was excellent, but the authors concluded that CoQ10 cannot currently be recommended as a routine treatment for Parkinson's disease. Honest reporting matters here: this is a domain where biological plausibility has not translated into clinical benefit.12

Exercise performance and muscle recovery

The 2025 meta-analysis by Qu & Qu (17 trials, 440 athletes) found significant reductions in creatine kinase (−71.8 IU/L), lactate dehydrogenase (−70 IU/L) and malondialdehyde, with the strongest effects at doses ≥ 300 mg/day. The effect on raw athletic performance remains modest, but post-exercise recovery is measurably enhanced.8

Liver health (metabolic steatotic liver disease)

The 2023 meta-analysis by Ardekani et al. (6 RCTs in patients with NAFLD/MASLD) reported overall non-significant reductions in lipid profile and liver enzymes, although subgroup analyses suggested benefits at higher doses (≥ 200 mg/day) over longer durations. The evidence is still preliminary and CoQ10 should not be considered a primary therapy for fatty liver disease.13

IndicationStudied doseLevel of evidenceBenefit
Chronic heart failure 3 × 100 mg/day Multicentre RCT (Q-SYMBIO)
Hypertension 100–200 mg/day GRADE meta-analysis (26 RCTs)
Migraine prophylaxis 200–300 mg/day Meta-analysis (6 RCTs)
Type 2 diabetes (adjunct) 100–200 mg/day Meta-analysis (13 RCTs)
Male fertility 200–300 mg/day Meta-analysis (15 RCTs)
Statin myopathy 100–200 mg/day Conflicting evidence
Parkinson's disease 300–2 400 mg/day Meta-analysis: not superior to placebo

CoQ10 and statins: what every patient should know

How statins deplete CoQ10 via the mevalonate pathway

Statins lower cholesterol by inhibiting HMG-CoA reductase — a key enzyme in the mevalonate pathway. The same pathway is required for CoQ10 biosynthesis, so statin therapy can lower plasma CoQ10 by up to 40 %, depending on dose and treatment duration.

Statin-induced myopathy: muscle pain, weakness and fatigue

Between 5 % and 15 % of statin users experience muscle symptoms — pain, cramps, weakness, exercise intolerance — collectively known as statin-associated muscle symptoms (SAMS). Whether CoQ10 depletion is causally responsible has been debated for decades.

Does supplementing CoQ10 actually help statin users?

The evidence is genuinely mixed. The meta-analysis by Qu et al. (2018, 12 RCTs, 575 patients) reported a significant reduction in statin-associated muscle pain and weakness with 100–200 mg/day. Wei et al. (2021), however, found no significant effect. The more recent 2025 meta-analysis by Kovacic et al. (7 RCTs, 389 patients) ultimately confirmed a modest but significant reduction in pain. Supplementation is therefore a reasonable adjunct, not a guaranteed solution.4

Recommended approach for statin users

For patients tolerating statins well, supplementation is not necessary. For those with bothersome muscle symptoms, a 100–200 mg/day trial over 8–12 weeks is reasonable, ideally discussed with the prescribing physician.

CoQ10 deficiency: causes, symptoms and risk groups

Why "coenzyme Q10 danger" is a misleading search term

The phrase "CoQ10 danger" appears frequently in search engines, but it usually conflates two different concerns: side effects of supplementation (rare and mild, see Section 9) and the consequences of CoQ10 deficiency itself. Genuinely low CoQ10 levels are linked to fatigue, muscle weakness and reduced exercise tolerance — symptoms that are non-specific and easily attributed to other causes.

Common causes of low CoQ10

It is useful to distinguish two situations. Primary CoQ10 deficiency is a rare genetic condition affecting the biosynthesis pathway, typically diagnosed in childhood and presenting with severe mitochondrial symptoms (Hargreaves 2020). What most adults experience is secondary deficiency — an age- or drug-related decline in tissue and plasma concentrations. Common contributors include age over 40, statin therapy, chronic oxidative stress, poor intestinal absorption, smoking, type 2 diabetes and chronic heart failure.14

Symptoms of CoQ10 deficiency

Persistent fatigue, muscle weakness and pain, exercise intolerance, slow recovery, brain fog and cognitive slowing. Routine plasma CoQ10 measurement is not standardised in clinical practice, so diagnosis remains largely clinical.

Who is most at risk?

Adults over 40–50 years, statin users, smokers, patients with chronic heart failure, type 2 diabetes, chronic migraine, fibromyalgia or neurodegenerative disorders, as well as endurance athletes during high-volume training periods.

Natural food sources of CoQ10

Best dietary sources

The richest sources are organ meats (heart, liver, kidney), oily fish (sardines, mackerel, salmon, tuna, herring), beef and pork. Plant-based contributors are more modest: soybeans, peanuts, pistachios, sesame seeds, broccoli, spinach and cauliflower. A balanced Swiss diet typically provides between 5 and 10 mg/day.

Why food intake alone is rarely sufficient

The therapeutic doses studied in clinical trials (100–300 mg/day) are 10 to 30 times higher than typical dietary intake. For preventive supplementation in adults over 40 — or anyone with one of the risk factors above — a well-designed daily multivitamin is often more practical than relying solely on diet, especially since CoQ10 acts in synergy with several B vitamins, vitamin E and magnesium for energy metabolism.

🇨🇭 Developed and made in Switzerland

VitaMix — Swiss multivitamin with coenzyme Q10

22 micronutrients in a single daily capsule — including 50 mg of coenzyme Q10, NAC, quercetin, and bioactive B vitamins, which contribute to normal energy-yielding metabolism (EFSA-authorised claim). A complete daily foundation designed for adults over 40 who want a simple, complete routine — without juggling multiple bottles.

  • 50 mg of coenzyme Q10 + 22 synergistic micronutrients
  • Bioactive forms: Quatrefolic® B9, methylcobalamin B12
  • 1 capsule per day — plant-based HPMC capsule
  • Swiss manufacturing — compliant with FSVO/OSAV standards
Discover VitaMix →

⚠️ Food supplement. Not a substitute for a varied and balanced diet or a healthy lifestyle.

Ubiquinone vs ubiquinol: which form should you choose?

What is ubiquinone? The oxidised, inactive form

Ubiquinone is the most common form found in supplements and is the cheaper of the two. Once absorbed, the body converts it into ubiquinol via tissue-specific reductases — provided this conversion capacity remains intact.

What is ubiquinol? The active, reduced form

Ubiquinol is the biologically active, antioxidant form. Roughly 90 % of plasma CoQ10 in healthy adults circulates in this form. It is more chemically unstable and more expensive to produce, but more readily absorbed.

Bioavailability: ubiquinol absorbs about 1.7× better

The crossover study by Langsjoen & Langsjoen (2014, 12 healthy subjects) compared 200 mg/day of each form over four weeks: plasma CoQ10 reached 4.3 µg/mL with ubiquinol versus 2.5 µg/mL with ubiquinone (P < 0.005). Other trials nuance this gap depending on age, formulation (oily soft gels, liposomal carriers) and individual conversion capacity.6

×1.7 higher plasma CoQ10 with ubiquinol versus ubiquinone at equal daily dose (200 mg/day, 4 weeks).

Who should opt for ubiquinol?

Adults over 60, patients with chronic heart failure, reduced hepatic conversion capacity, or chronic inflammatory conditions. For healthy younger adults, well-formulated ubiquinone in oil-based soft gels remains the most cost-effective choice.

💡 Practical advice

Ubiquinone is the rational default for healthy adults under 60. Ubiquinol becomes worthwhile when there is a chronic condition, with advancing age, or when an initial ubiquinone trial has produced no perceptible benefit after 8–12 weeks.

CoQ10 dosage: evidence-based recommendations

General preventive use: 30–100 mg/day

For adults without a specific clinical indication who simply want to support cellular energy and antioxidant defence after age 40, 30–100 mg/day is sufficient. This range is also the one typically found in well-formulated daily multivitamins.

Therapeutic dosages by condition

Cardiovascular conditions (heart failure, hypertension): 100–300 mg/day. Migraine prophylaxis: 200–300 mg/day over 8–12 weeks (Sándor 2005). Type 2 diabetes adjunct: 100–200 mg/day (Zhang 2018). Statin-induced muscle symptoms: 100–200 mg/day. Anti-inflammatory effect: 300–400 mg/day (Hou 2023). Athletic recovery: ≥ 300 mg/day. Clinical safety has been demonstrated up to 1 200 mg/day in adult trials, with no serious adverse events reported.9

100–200 mg/day covers the optimal range for most cardiovascular indications, based on the U-shaped dose–response observed in the GRADE meta-analysis (Zhao 2022).

How to take CoQ10 for maximum absorption

Because CoQ10 is fat-soluble, intestinal absorption increases two- to threefold when taken with a fat-containing meal — olive oil, avocado, oily fish, nuts, full-fat yoghurt. Taken on an empty stomach, bioavailability drops significantly.

💡 Absorption tip

Take CoQ10 with breakfast or lunch when these include healthy fats: a full-fat yoghurt, a handful of walnuts, a drizzle of olive oil on vegetables, or half an avocado will all enhance intestinal uptake.

Best time of day

Morning or midday with a fat-containing meal. Late-evening intake may disturb sleep in sensitive individuals due to the metabolic stimulation. Daily doses above 200 mg are best split into two intakes to prevent absorption ceiling effects.

Is CoQ10 safe? Side effects, risks and drug interactions

CoQ10 has one of the strongest safety profiles among common food supplements. Less than 1 % of users report side effects in clinical trials, and the Observed Safety Level (OSL) has been established at 1 200 mg/day/person based on long-term clinical safety data (Hidaka 2008).15 Side effects, when they occur, are typically mild. A few specific situations warrant medical advice:

  • Mild digestive upset (nausea, heartburn, soft stools), occasional headache, insomnia or skin rash — typically dose-dependent and reversible.
  • Vitamin K antagonists (warfarin, phenprocoumon, acenocoumarol): may reduce anticoagulant efficacy by accelerating hepatic warfarin metabolism (Zhou 2005). INR monitoring is essential.
  • Antihypertensives: possible additive blood pressure-lowering effect — monitoring recommended at treatment initiation.
  • Insulin and oral antidiabetics: dose adjustment may be required as glucose control may improve.
  • Chemotherapy and radiotherapy: oncology approval is mandatory before any supplementation, as antioxidants may theoretically interfere with treatment efficacy.
  • Planned surgery: as a precaution, discontinue 1–2 weeks before any scheduled surgical procedure, in line with conservative perioperative guidance for antioxidants.
  • Pregnancy and breastfeeding: not recommended without medical advice, due to insufficient safety data.
  • Minors under 18: supplementation only under specialised medical supervision.

Outside these situations, CoQ10 supplementation has been studied at doses up to 1 200 mg/day in long-term adult trials without serious adverse events — making it one of the best-tolerated supplements in clinical practice.

Buying CoQ10 in Switzerland: what to look for

Key quality criteria on the label

Four criteria distinguish a high-quality CoQ10 supplement from a mediocre one:

  • Bio-identical CoQ10 obtained by natural yeast fermentation (not synthetic isomers), ideally with the Kaneka Q10™ label — the raw material used in the majority of clinical trials indexed on PubMed.
  • Optimised galenic formulation: oil-based soft gels, liposomal or micellar formulations offer significantly higher bioavailability than dry tablets and chewables.
  • Adequate dose and purity: at least 100 mg per serving, with no unnecessary additives (magnesium stearate, titanium dioxide, artificial colourants), and an independent third-party certificate of analysis.
  • Swiss manufacturing compliant with the Federal Food Safety and Veterinary Office (FSVO/OSAV) — among the strictest food supplement standards in Europe, ensuring full traceability.

Available supplement forms

Oil-based soft gel capsules (most studied form), liposomal preparations, plant-based HPMC capsules with crystal-dispersed CoQ10, and chewable tablets. Soft gels and liposomal formulations show the highest bioavailability.

Where to buy and typical pricing

In Switzerland, CoQ10 is sold without prescription in pharmacies, drugstores, organic food shops and from Swiss-based online retailers. Typical pricing for a one-month supply (100 mg/day) ranges from CHF 25 to CHF 60, depending on the form (ubiquinone vs ubiquinol), the raw material and the brand. Swiss-made supplements compliant with FSVO/OSAV standards offer the best traceability guarantees on the European market.

Key takeaways

  • Mechanism Essential cofactor for ATP production in the mitochondrial respiratory chain and a powerful fat-soluble antioxidant.
  • Strongest evidence Chronic heart failure (Q-SYMBIO), systolic blood pressure, migraine prophylaxis, type 2 diabetes (adjunct), male fertility.
  • Dosage 100–200 mg/day for most indications, taken with a fat-containing meal.
  • Caution Interaction with vitamin K antagonists (warfarin) — INR monitoring required. Discontinue 1–2 weeks before scheduled surgery. Medical advice during chemotherapy and pregnancy.

Frequently asked questions about CoQ10

What is CoQ10 coenzyme good for?

CoQ10 supports cellular energy production and acts as an antioxidant. The strongest clinical evidence concerns chronic heart failure (Q-SYMBIO trial), systolic blood pressure, migraine prophylaxis, type 2 diabetes (as an adjunct) and male fertility.

Why don't doctors always recommend CoQ10?

Because the evidence varies widely across indications. For some conditions (heart failure, hypertension, migraine), the data are solid. For others (Parkinson's disease, fatty liver disease), recent meta-analyses show no significant benefit. Physicians also tend to prioritise validated medications over supplements unless a clinical rationale justifies the addition.

What happens when you take CoQ10 every day?

Plasma CoQ10 levels rise gradually over 4–8 weeks until they reach saturation. Most users notice no immediate change but report better exercise tolerance, less fatigue or improvement in target symptoms (migraine frequency, muscle pain) after 8–12 weeks. Tolerance is generally excellent at preventive doses.

Who should not take CoQ10?

People taking warfarin or other vitamin K antagonists (without INR monitoring), patients undergoing chemotherapy or radiotherapy without oncology approval, anyone scheduled for surgery within the next 1–2 weeks, pregnant or breastfeeding women without medical advice, and minors under 18 outside specialist supervision.

Is ubiquinol better than ubiquinone?

Ubiquinol shows about 1.7× higher plasma levels at equal doses (Langsjoen 2014). It is preferable after age 60, in chronic heart failure, or when conversion capacity may be reduced. For healthy adults under 60, well-formulated ubiquinone in oil-based soft gels remains a cost-effective option.

How long does it take for CoQ10 to work?

Plasma saturation is gradual. Most clinical trials report measurable effects after 8 to 12 weeks of consistent daily use, taken with a fat-containing meal. Consistency matters more than dose magnitude in single intakes.

Can I take CoQ10 with magnesium and vitamin B6?

Yes. CoQ10 combines well with magnesium, vitamin B6 and the wider B vitamin complex — these nutrients act synergistically in mitochondrial energy metabolism. This is one rationale for choosing a comprehensive multivitamin rather than a stand-alone supplement when the goal is preventive.

Is CoQ10 available without a prescription in Switzerland?

Yes. CoQ10 is regulated as a food supplement by the Federal Food Safety and Veterinary Office (FSVO/OSAV) and is available in pharmacies, drugstores and online retailers without prescription. Swiss manufacturing ensures one of the strictest traceability frameworks in Europe.

What is the difference between CoQ10 and vitamin Q10?

They refer to the same molecule. "Vitamin Q10" is a colloquial term, but technically CoQ10 is not a true vitamin because the body synthesises it endogenously. The scientifically accurate name is coenzyme Q10 or ubiquinone/ubiquinol.

Can CoQ10 reduce statin side effects?

The evidence is mixed but leans positive. Qu et al. (2018, 12 RCTs, 575 patients) and Kovacic et al. (2025, 7 RCTs) both show modest but significant reductions in statin-associated muscle pain and weakness with 100–200 mg/day. Wei et al. (2021) found no effect. A pragmatic 8–12 week trial under medical supervision is reasonable for symptomatic patients.

Scientific sources (PubMed-validated)

1

Mortensen et al. (2014) — Q-SYMBIO trial on mortality in chronic heart failure

JACC: Heart Failure, 2(6):641–9. Multicentre RCT, 420 patients, 2-year follow-up.

DOI
2

Zhao et al. (2022) — GRADE dose–response meta-analysis on blood pressure

Advances in Nutrition, 13(6):2180–2194. 26 RCTs, 1 831 cardiometabolic subjects.

DOI
3

Hou et al. (2023) — GRADE meta-analysis on inflammatory markers

Mol Nutr Food Res, 67(13):e2200800. 31 RCTs, 1 517 subjects; CRP, IL-6 and TNF-α.

DOI
4

Qu et al. (2018) — Meta-analysis on statin-induced myopathy

J Am Heart Assoc, 7(19):e009835. 12 RCTs, 575 patients.

DOI
5

Sándor et al. (2005) — RCT on migraine prophylaxis 🇨🇭

Neurology, 64(4):713–5. Conducted at the University Hospital of Zurich.

DOI
6

Langsjoen & Langsjoen (2014) — Ubiquinol vs ubiquinone bioavailability

Clin Pharmacol Drug Dev, 3(1):13–7. Crossover study, 12 healthy adults.

DOI
7

Lain et al. (2024) — Review on CoQ10 and skin ageing

J Clin Aesthet Dermatol, 17(8):50–55. Review of 36 PubMed publications.

PMID
8

Qu & Qu (2025) — Meta-analysis on athletes (CK, LDH, MDA)

Complement Ther Clin Pract, 60:102001. 17 trials, 440 athletes.

DOI
9

Shults et al. (2004) — Safety of high-dose CoQ10

Exp Neurol, 188(2):491–4. Doses tested up to 3 000 mg/day, well tolerated.

DOI
10

Zhang et al. (2018) — Meta-analysis on type 2 diabetes

Int J Endocrinol, 2018:6484839. 13 RCTs, 765 patients; HbA1c −0.29, FBG −11.21 mg/dL.

DOI
11

Salas-Huetos et al. (2018) — Meta-analysis on sperm quality

Adv Nutr, 9(6):833–848. 28 articles, 15 RCTs; sperm concentration +5.93×10⁶/mL, motility +5.30 %.

DOI
12

Zhu et al. (2016) — Meta-analysis on Parkinson's disease (negative result)

Neurol Sci, 38(2):215–224. 8 RCTs, 899 patients; not superior to placebo on motor symptoms.

DOI
13

Ardekani et al. (2023) — Meta-analysis on NAFLD/MASLD

Food Sci Nutr, 11(6):2580–2588. 6 RCTs; overall non-significant effects on lipid profile and liver enzymes.

DOI
15

Hidaka et al. (2008) — Safety assessment of coenzyme Q10

Biofactors, 32(1-4):199–208. Comprehensive safety review; Observed Safety Level (OSL) established at 1 200 mg/day/person.

DOI
14

Hargreaves et al. (2020) — Disorders of human coenzyme Q10 metabolism: an overview

Int J Mol Sci, 21(18):6695. Review on primary and secondary CoQ10 deficiencies.

DOI

Informational article validated against PubMed sources. Does not replace medical advice. Swiss reference body: FSVO/OSAV — Federal Food Safety and Veterinary Office.